{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T01:05:22Z","timestamp":1760144722431,"version":"build-2065373602"},"reference-count":17,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","onlinecjc.ca","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Canadian Journal of Cardiology"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.cjca.2020.03.030","type":"journal-article","created":{"date-parts":[[2020,3,31]],"date-time":"2020-03-31T02:05:12Z","timestamp":1585620312000},"page":"1569-1571","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Fluoroscopy-Only Guided Patent Foramen Ovale Device Closure: Will It Cut Ice With the Interventionalist Community?"],"prefix":"10.1016","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0302-1419","authenticated-orcid":false,"given":"Anoop","family":"Mathew","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dylan","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cjca.2020.03.030_bib1","first-page":"1","article-title":"Patent foramen ovale closure for stroke prevention and other disorders","volume":"7","author":"Collado","year":"2018","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.cjca.2020.03.030_bib2","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1056\/NEJMoa1009639","article-title":"Closure or medical therapy for cryptogenic stroke with patent foramen ovale","volume":"366","author":"Furlan","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjca.2020.03.030_bib3","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1056\/NEJMoa1211716","article-title":"Percutaneous closure of patent foramen ovale in cryptogenic embolism","volume":"368","author":"Meier","year":"2013","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjca.2020.03.030_bib4","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1056\/NEJMoa1610057","article-title":"Long-term outcomes of patent foramen ovale closure or medical therapy after stroke","volume":"377","author":"Saver","year":"2017","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjca.2020.03.030_bib5","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1056\/NEJMoa1707404","article-title":"Patent foramen ovale closure or antiplatelet therapy for cryptogenic stroke","volume":"377","author":"S\u00f8ndergaard","year":"2017","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjca.2020.03.030_bib6","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1016\/j.jacc.2018.02.046","article-title":"Cryptogenic stroke and high-risk patent foramen ovale","volume":"71","author":"Lee","year":"2018","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2020.03.030_bib7","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1093\/eurheartj\/ehy121","article-title":"Patent foramen ovale closure vs medical therapy for cryptogenic stroke: a meta-analysis of randomized controlled trials","volume":"39","author":"Ahmad","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cjca.2020.03.030_bib8","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/j.echo.2015.05.015","article-title":"Guidelines for the echocardiographic assessment of atrial septal defect and patent foramen ovale: from the American Society of Echocardiography and Society for Cardiac Angiography and Interventions","volume":"28","author":"Silvestry","year":"2015","journal-title":"J\u00a0Am Soc Echocardiogr"},{"key":"10.1016\/j.cjca.2020.03.030_bib9","first-page":"105","article-title":"PFO closure with only fluoroscopic guidance: 7 years real-world single centre experience","volume":"86","author":"Mangieri","year":"2015","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.cjca.2020.03.030_bib10","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1111\/echo.13842","article-title":"Angiography vs transesophageal echocardiography\u2013guided patent foramen ovale closure: a propensity score matched analysis of a two-center registry","volume":"35","author":"Scacciatella","year":"2018","journal-title":"Echocardiography"},{"key":"10.1016\/j.cjca.2020.03.030_bib11","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.ihj.2017.07.020","article-title":"Simplified percutaneous closure of patent foramen ovale and atrial septal defect with use of plain fluoroscopy: single operator experience in 110 consecutive patients","volume":"70","author":"Manolis","year":"2018","journal-title":"Indian Heart J"},{"key":"10.1016\/j.cjca.2020.03.030_bib12","first-page":"280","article-title":"Propensity-score matched comparison of the Cera PFO Occluder with the Amplatzer PFO Occluder for percutaneous closure of patent foramen ovale without echocardiographic guidance","volume":"29","author":"Ulmi","year":"2017","journal-title":"J\u00a0Invasive Cardiol"},{"key":"10.1016\/j.cjca.2020.03.030_bib13","doi-asserted-by":"crossref","first-page":"567","DOI":"10.4414\/smw.2008.12255","article-title":"Safety and feasibility of percutaneous closure of patent foramen ovale without intra-procedural echocardiography in 825 patients","volume":"138","author":"Wahl","year":"2008","journal-title":"Swiss Med Wkly"},{"key":"10.1016\/j.cjca.2020.03.030_bib14","first-page":"361","article-title":"Is routine ultrasound guidance really necessary for closure of patent foramen ovale using the Amplatzer PFO Occluder?","volume":"73","author":"Fateh-Moghadam","year":"2009","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.cjca.2020.03.030_bib15","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1111\/joic.12325","article-title":"Long-term outcomes and complications of intracardiac echocardiography-assisted patent foramen ovale closure in 1,000 consecutive patients","volume":"29","author":"Rigatelli","year":"2016","journal-title":"J\u00a0Interv Cardiol"},{"key":"10.1016\/j.cjca.2020.03.030_bib16","doi-asserted-by":"crossref","first-page":"24","DOI":"10.4065\/79.1.24","article-title":"Intracardiac echocardiographic guidance during transcatheter device closure of atrial septal defect and patent foramen ovale","volume":"79","author":"Earing","year":"2004","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.cjca.2020.03.030_bib17","first-page":"1608","article-title":"Periprocedural outcomes of fluoroscopy-guided patent foramen ovale closure with selective use of intracardiac echocardiography","volume":"36","author":"Barker","year":"2020","journal-title":"Can J Cardiol"}],"container-title":["Canadian Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0828282X20303032?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0828282X20303032?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T14:44:09Z","timestamp":1760107449000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0828282X20303032"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":17,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["S0828282X20303032"],"URL":"https:\/\/doi.org\/10.1016\/j.cjca.2020.03.030","relation":{},"ISSN":["0828-282X"],"issn-type":[{"type":"print","value":"0828-282X"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fluoroscopy-Only Guided Patent Foramen Ovale Device Closure: Will It Cut Ice With the Interventionalist Community?","name":"articletitle","label":"Article Title"},{"value":"Canadian Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cjca.2020.03.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.cjca.2019.12.032","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Canadian Cardiovascular Society. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}